Abstract
Intoxications are common in emergency medicine. Most of these intoxications involve analgesics, sedatives and cardiovascular drugs. Enhanced elimination of the toxic agent is one of the cornerstones of the management of the intoxicated patient. The use of renal replacement therapy to remove a toxin is justified if there is an indication of severe toxicity and if the total body elimination of the toxin can be increased by 30% or more using this technique. Whether removal of toxins by means of renal replacement therapy is possible, depends on characteristics of the toxin itself and of the elimination technique used. In this chapter, we will give an overview of the indications and techniques for the elimination of toxic agents.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bronstein AC, Spyker DA, Cantilena LR. 2011 Annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 29th Annual Report. Clin Toxicol. 2012;50:911–1164.
Soar J, Perkins GD, Abbas G, et al. European Resuscitation Council guidelines for resuscitation 2010 section 8: cardiac arrest in special circumstances: electrolyte abnormalities, poisoning, drowning, accidental hypothermia, hyperthermia, asthma, anaphylaxis, cardiac surgery, trauma, pregnancy, electrocution. Resuscitation. 2010;18:1400–33.
Orlowski JM, Hou S, Leikin JB. Extracorporeal removal of drugs and toxins. In: Ford M, Delaney KA, Ling L, et al., editors. Clinical toxicology. 1st ed. St. Louis: WB Saunders Company; 2001. p. 43–50.
de Pont AC. Extracorporeal treatment of intoxications. Curr Opin Crit Care. 2007;13:668–73.
Ronco C. Recent evolution of renal replacement therapy in the critically ill patient. Crit Care. 2006;10:123.
Matzke GR, Aronoff GR, Atkinson Jr AJ, et al. Drug dosing consideration in patients with acute and chronic kidney disease – a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2011;80:1122–37.
Fertel BS, Nelson LS, Goldfarb DS. Extracorporeal removal techniques for the poisoned patient: a review for the intensivist. J Intensive Care Med. 2010;25:139–48.
Suresh M, Farrington K. Principles of extracorporeal therapy: haemodialysis, haemofiltration and haemodiafiltration. In: Jörres A, Ronco C, Kellum J, editors. Management of acute kidney problems. 1st ed. Berlin/Heidelberg: Springer; 2010. p. 481–9.
Munshi R, Ahmad S. Comparison of urea clearance in low efficiency low-flux vs. high-efficiency high-flux dialyzer membrane with reduced blood and dialysate flow: an in vitro analysis. Hemodial Int. 2014;18:172–4.
Vinsonneau C, Benyamina M. Intermittent hemodialysis. In: Jörres A, Ronco C, Kellum J, editors. Management of acute kidney problems. 1st ed. Berlin/Heidelberg: Springer; 2010. p. 515–23.
Bogard KN, Peterson NT, Plumb TJ, et al. Antibiotic dosing during sustained low efficiency dialysis: special considerations in adult critically ill patients. Crit Care Med. 2011;39:560–70.
Barshes NR, Gay N, Williams B, et al. Support for the acutely failing liver: a comprehensive review of historic and contemporary strategies. J Am Coll Surg. 2005;201:458–76.
Shalkham AS, Kirrane BM, Hoffman RS, et al. The availability and use of charcoal hemoperfusion in the treatment of poisoned patients. Am J Kidney Dis. 2006;48:239–41.
Erickson TB, Thompson TM, Lu JJ. The approach to the patient with an unknown overdose. Emerg Med Clin North Am. 2007;25:249–81.
Roberts DM, Buckley NA. Enhanced elimination in acute barbiturate poisoning – a systematic review. Clin Toxicol (Phila). 2011;49:2–12.
Palmer BF. Effectiveness of hemodialysis in the extracorporeal therapy of phenobarbital overdose. Am J Kidney Dis. 2000;36:640–3.
Jacobs F, Brivet FG. Conventional haemodialysis significantly lowers toxic levels of phenobarbital. Nephrol Dial Transplant. 2004;19:1663–4.
Eyer F, Pfab R, Felgenhauer N, et al. Lithium poisoning: pharmacokinetics and clearance during different therapeutic measures. J Clin Pharmacol. 2006;26:325–30.
Borras-Blasco J, Sirvent AD, Navarro-Ruiz A, et al. Unrecognized delayed toxic lithium peak concentration in acute poisoning with sustained release lithium product. South Med J. 2007;100:321–3.
Galea M, Jelacin N, Bramham K, et al. Severe lactic acidosis and rhabdomyolysis following metformin and ramipril overdose. Br J Anaesth. 2007;98:213–5.
Davidson MB, Peters AL. An overview of metformin in the treatment of type 2 diabetes mellitus. Am J Med. 1997;102:99–110.
Lalau JD, Andrejak M, Morinière P, et al. Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin: a study of metformin elimination. Int J Clin Pharmacol Ther Toxicol. 1989;27:1285–8.
Spiller HA, Sawyer TS. Toxicology of oral antidiabetic medications. Am J Health Syst Pharm. 2006;63:929–38.
Alivanis P, Giannikouris I, Paliuras C, et al. Metformin associated lactic acidosis treated with continuous renal replacement therapy. Clin Ther. 2006;28:396–400.
Guo PY, Storsley LJ, Finkle SN. Severe lactic acidosis treated with prolonged hemodialysis: recovery after massive overdoses of metformin. Semin Dial. 2006;19:80–3.
O’Malley GF. Emergency department management of the salicylate poisoned patient. Emerg Med Clin North Am. 2007;25:333–46.
Dargan PI, Wallace CI, Jones AL. An evidence based flowchart to guide the management of acute salicylate (aspirin) overdose. Emerg Med J. 2002;19:206–9.
Henderson JH, McKenzie CA, Hilton PJ, et al. Continuous venovenous haemofiltration for the treatment of theophylline toxicity. Thorax. 2001;56:242–3.
Mycyk MB, DesLauriers C, Metz J, et al. Compliance with poison center fomepizole recommendations is suboptimal in cases of toxic alcohol poisoning. Am J Ther. 2006;13:485–9.
Mégarbane B, Borron SW, Baud FJ. Current recommendations for treatment of severe toxic alcohol poisonings. Intensive Care Med. 2005;31:189–95.
Moreau CL, Kerns II W, Tomaszewski CA, et al. Glycolate kinetics and hemodialysis clearance in ethylene glycol poisoning. J Toxicol Clin Toxicol. 1998;36:659–66.
Barceloux DG, Bond GR, Krenzelok EP, et al. American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol. 2002;40:415–46.
Kerns II W, Tomaszewski C, McMartin K, et al. Formate kinetics in methanol poisoning. J Toxicol Clin Toxicol. 2002;40:137–43.
Abramson S, Singh AK. Treatment of the alcohol intoxications: ethylene glycol, methanol and isopropanol. Curr Opin Nephrol Hypertens. 2000;9:695–701.
Al Aly Z, Yalamanchili P, Gonzalez E. Extracorporeal management of valproic acid toxicity: a case report and review of the literature. Semin Dial. 2005;18:62–6.
Meek MF, Broekroelofs J, Yska JP, et al. Valproic acid intoxication: sense and nonsense of haemodialysis. Neth J Med. 2004;62:333–6.
Singh SM, McCormick BB, Mustata S, et al. Extracorporeal management of valproic acid overdose: a large regional experience. J Nephrol. 2004;17:43–9.
Goodman JW, Goldfarb DS. The role of continuous venovenous replacement therapy in the treatment of poisoning. Semin Dial. 2006;19:402–7.
Sztajnkrycer MD. Valproic acid toxicity: overview and management. J Toxicol Clin Toxicol. 2002;40:789–801.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing
About this chapter
Cite this chapter
de Pont, AC.J.M. (2015). Renal Replacement Therapy for Intoxications. In: Oudemans-van Straaten, H., Forni, L., Groeneveld, A., Bagshaw, S., Joannidis, M. (eds) Acute Nephrology for the Critical Care Physician. Springer, Cham. https://doi.org/10.1007/978-3-319-17389-4_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-17389-4_19
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-17388-7
Online ISBN: 978-3-319-17389-4
eBook Packages: MedicineMedicine (R0)